首页> 外文期刊>Genetic Testing >The CFTR M470V Gene Variant as a Potential Modifier of COPD Severity: Study of Serbian Population
【24h】

The CFTR M470V Gene Variant as a Potential Modifier of COPD Severity: Study of Serbian Population

机译:CFTR M470V基因变异作为COPD严重程度的潜在修饰因素:塞尔维亚人口的研究

获取原文
获取原文并翻译 | 示例
       

摘要

Chronic obstructive pulmonary disease (COPD) is a complex disease influenced by genetic and environmental factors. Cystic fibrosis transmembrane conductance regulator (CFTR) protein is an important component of the lung tissue homeostasis, involved in the regulation of the rate of mucociliary clearance. As it is known that certain CFTR variants have consequences on the function of CFTR protein, the aim of this study was to examine the possible role of F508del, M470V, Tn locus, and R75Q variants in COPD development and modulation. Total number of 86 COPD patients and 102 control subjects were included in the study. Possible association between COPD susceptibility, severity, and onset of the disease and allele or genotype of four analyzed CFTR variants was examined. No associations were detected between COPD development, onset of the disease and tested CFTR alleles and genotypes. However, VV470 genotype was associated with mild/moderate COPD stages in comparison to severe/very severe ones (OR = 0.29, 95%CI = 0.11–0.80, p = 0.016). Our study showed that patients with VV470 genotype had a 3.4-fold decreased risk for the appearance of severe/very severe COPD symptoms, and the obtained results indicate that this genotype may have a protective role. These results also suggest the importance of studying CFTR gene as a modifier of this disease
机译:慢性阻塞性肺疾病(COPD)是受遗传和环境因素影响的复杂疾病。囊性纤维化跨膜电导调节剂(CFTR)蛋白是肺组织动态平衡的重要组成部分,参与了对粘膜纤毛清除率的调节。众所周知,某些CFTR变体会影响CFTR蛋白的功能,因此本研究的目的是研究F508del,M470V,Tn基因座和R75Q变体在COPD发育和调节中的可能作用。该研究共包括86名COPD患者和102名对照受试者。检查了COPD敏感性,严重性和疾病发作与四种分析的CFTR变异的等位基因或基因型之间的可能联系。在COPD发生,疾病发作和测试的CFTR等位基因与基因型之间未发现关联。然而,与重度/非常重度相比,VV470基因型与轻度/中度COPD分期相关(OR = 0.29,95%CI = 0.11-0.80,p = 0.016)。我们的研究表明,具有VV470基因型的患者出现严重/非常严重的COPD症状的风险降低了3.4倍,并且获得的结果表明该基因型可能具有保护作用。这些结果也表明研究CFTR基因作为该疾病的修饰基因的重要性。

著录项

  • 来源
    《Genetic Testing》 |2008年第3期|p.357-362|共6页
  • 作者单位

    Marija StankovicInstitute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.Aleksandra NikolicInstitute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.Aleksandra DivacInstitute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.Andrija TomovicFriedrich Miescher Institute for Biomedical Research, Part of the Novartis Research Foundation, Basel, Switzerland.Natasa Petrovic-StanojevicZvezdara University Medical Center, Belgrade, Serbia.Marina AndjelicZvezdara University Medical Center, Belgrade, Serbia.Vesna Dopudja-PanticZvezdara University Medical Center, Belgrade, Serbia.Mirjana SurlanZvezdara University Medical Center, Belgrade, Serbia.Ivan VujicicZvezdara University Medical Center, Belgrade, Serbia.Dimitrije PonomarevZvezdara University Medical Center, Belgrade, Serbia.Marija Mitic-MilikicInstitute for Tuberculosis and Lung Disease, University Clinical Center of Serbia, Belgrade, Serbia.Jelena KusicInstitute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.Dragica RadojkovicInstitute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Study of Serbian Population;

    机译:塞尔维亚人口研究;
  • 入库时间 2022-08-17 23:43:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号